Decreasing potassium conductance--a possible mechanism of phasic coronary vasospasm

Jpn Circ J. 1985 Jan;49(1):128-39. doi: 10.1253/jcj.49.128.
No abstract available

MeSH terms

  • 4-Aminopyridine* / analogs & derivatives*
  • Amifampridine
  • Aminopyridines / pharmacology
  • Animals
  • Calcium / metabolism
  • Coronary Vasospasm / etiology*
  • Coronary Vasospasm / metabolism
  • Coronary Vasospasm / pathology
  • Coronary Vessels / pathology
  • Coronary Vessels / physiology
  • Dogs
  • Ergonovine / analogs & derivatives
  • Ergonovine / pharmacology
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • In Vitro Techniques
  • Macaca mulatta
  • Male
  • Membrane Potentials / drug effects
  • Muscle Contraction / drug effects
  • Muscle Relaxation / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Myocardium / metabolism
  • Niacinamide / analogs & derivatives
  • Niacinamide / pharmacology
  • Nicorandil
  • Nifedipine / pharmacology
  • Potassium / metabolism*
  • Swine
  • Tetraethylammonium
  • Tetraethylammonium Compounds / pharmacology

Substances

  • Aminopyridines
  • Tetraethylammonium Compounds
  • Niacinamide
  • Nicorandil
  • Tetraethylammonium
  • 4-Aminopyridine
  • Nifedipine
  • Amifampridine
  • Potassium
  • Calcium
  • Ergonovine